Cost-Effectiveness of Betrixaban Compared With Enoxaparin for Venous Thromboembolism Prophylaxis in Nonsurgical Patients With Acute Medical Illness in the United States

PharmacoEconomics - United Kingdom
doi 10.1007/s40273-018-0757-8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Pcv85 - Cost-Effectiveness of Betrixaban Compared With Enoxaparin or Fondaparinux for Venous Thromboembolism Prophylaxis in Hospitalised Acute Medically Ill Patients in the United Kingdom

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Enoxaparin Dosing for Venous Thromboembolism Prophylaxis in Low Body Weight Patients

Clinical Medicine Insights: Blood Disorders
Hematology
2019English

Cost Effectiveness of Prophylaxis of Venous Thromboembolism

Journal of the Royal Society of Medicine
Medicine
1981English

The Cost-Effectiveness of Dabigatran Etexilate Compared With Rivaroxaban in the Treatment of Acute Venous Thromboembolism in the Uk

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

The Cost-Effectiveness of Dabigatran Etexilate Compared With Edoxaban in the Treatment of Acute Venous Thromboembolism in the Uk

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Comparison of Chemical and Mechanical Prophylaxis of Venous Thromboembolism in Nonsurgical Mechanically Ventilated Patients

Thrombosis
Cardiovascular MedicineHematologyCardiology
2015English

Cost Effectiveness of Venous Thromboembolism Pharmacological Prophylaxis in Total Hip and Knee Replacement

PharmacoEconomics
Health PolicyPublic HealthOccupational HealthPharmacologyEnvironmental
2010English

Venous Thromboembolism Prophylaxis in Cancer Patients

2012English

Anticoagulant Activity of Enoxaparin and Unfractionated Heparin for Venous Thromboembolism Prophylaxis in Obese Patients Undergoing Sleeve Gastrectomy

Surgery for Obesity and Related Diseases
Surgery
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy